MIRXES-B早盘涨近8% 携手沃森深耕东盟市场共建RNA精准医疗创新体系

智通财经2025-11-24

MIRXES-B(02629)早盘涨近8%，截至发稿，涨2.48%，报53.8港元，成交额1829.42万港元。　　消息面上，11月18日，Mirxes觅瑞宣布与沃森生物（300142）(300142.SZ)正式签署谅解备忘录，双方将围绕分子诊断与疫苗研发领域开展深度合作，携手拓展东盟及全球市场。此次合作标志着精准诊断领军企业与顶尖疫苗研发企业实现战略协同，为构建以RNA为核心的预防及精准医疗平台...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2585459901?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-24 15:18","share_image_url":"https://static.laohu8.com/f0343184bd9b9c963ed02b302442e2b8","id":"2585459901","market":"sh","top_or_hot":-1,"title":"MIRXES-B早盘涨近8% 携手沃森深耕东盟市场 共建RNA精准医疗创新体系","media":"智通财经","content":"<div>\n<p>MIRXES-B(02629)早盘涨近8%，截至发稿，涨2.48%，报53.8港元，成交额1829.42万港元。　　消息面上，11月18日，Mirxes觅瑞宣布与沃森生物（300142）(300142.SZ)正式签署谅解备忘录，双方将围绕分子诊断与疫苗研发领域开展深度合作，携手拓展东盟及全球市场。此次合作标志着精准诊断领军企业与顶尖疫苗研发企业实现战略协同，为构建以RNA为核心的预防及精准医疗平台...</p>\n\n<a href=\"http://stock.10jqka.com.cn/hks/20251124/c672685724.shtml\">网页链接</a>\n\n</div>\n","source":"tonghuashun","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MIRXES-B早盘涨近8% 携手沃森深耕东盟市场 共建RNA精准医疗创新体系</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMIRXES-B早盘涨近8% 携手沃森深耕东盟市场 共建RNA精准医疗创新体系\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-24 15:18 北京时间&nbsp;&nbsp;&nbsp;<a href=http://stock.10jqka.com.cn/hks/20251124/c672685724.shtml><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MIRXES-B(02629)早盘涨近8%，截至发稿，涨2.48%，报53.8港元，成交额1829.42万港元。　　消息面上，11月18日，Mirxes觅瑞宣布与沃森生物（300142）(300142.SZ)正式签署谅解备忘录，双方将围绕分子诊断与疫苗研发领域开展深度合作，携手拓展东盟及全球市场。此次合作标志着精准诊断领军企业与顶尖疫苗研发企业实现战略协同，为构建以RNA为核心的预防及精准医疗平台...</p>\n\n<a href=\"http://stock.10jqka.com.cn/hks/20251124/c672685724.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0046","symbol_name":"生物疫苗","start_time":0,"source_url":"http://stock.10jqka.com.cn/hks/20251124/c672685724.shtml","article_id":"2585459901","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2585459901","pubTimestamp":1763968680,"columns":[],"sourceInfo":{"source_id":"tonghuashun","name":"同花顺"},"weMediaInfo":null,"summary":"MIRXES-B(02629)早盘涨近8%，截至发稿，涨2.48%，报53.8港元，成交额1829.42万港元。 消息面上，11月18日，Mirxes觅瑞宣布与沃森生物(300142.SZ)正式签署谅解备忘录，双方将围绕分子诊断与 ...","collect":0,"end_time":0,"defaultTopTitle":"10jqka.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300142":"沃森生物","BK0046":"生物疫苗","BK0239":"医药制造","BK0077":"质押式回购","BK0070":"员工持股"},"translate_title":"MIRXES-B rose nearly 8% in early trading, joining hands with Watson to deeply explore the ASEAN market and jointly build an RNA precision medical innovation system","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300142":1},"content_text":"MIRXES-B(02629)早盘涨近8%，截至发稿，涨2.48%，报53.8港元，成交额1829.42万港元。　　消息面上，11月18日，Mirxes觅瑞宣布与沃森生物（300142）(300142.SZ)正式签署谅解备忘录，双方将围绕分子诊断与疫苗研发领域开展深度合作，携手拓展东盟及全球市场。此次合作标志着精准诊断领军企业与顶尖疫苗研发企业实现战略协同，为构建以RNA为核心的预防及精准医疗平台奠定坚实基础。　　值得注意的是，今年10月，核心产品GASTROClear经中国国家药品监督管理局（NMPA）批准上市，成为全球首款也是目前唯一获批用于胃癌筛查的分子诊断IVD产品。方正证券发布研报称，这一里程碑事件不仅实现了公司“从0到1”的商业化突破，也为其带来价值重估新逻辑。此次获批意味着公司正式进入中国庞大的胃癌筛查市场，成为短期内最重要的业绩催化剂。 \n关注同花顺财经（ths518），获取更多机会","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2585459901","isCrawlerRequest":true}

MIRXES-B早盘涨近8% 携手沃森深耕东盟市场 共建RNA精准医疗创新体系

精彩评论

MIRXES-B早盘涨近8% 携手沃森深耕东盟市场共建RNA精准医疗创新体系